Characterization of ribosomal frameshifting in HIV-1 gag-pol expression
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Based on precedents from other retroviruses, the precursor of the human immunodeficiency virus (HIV-1) reverse transcriptase is predicted to be a polyprotein with a relative molecular mass (Mr) of 160,000 (160K) encoded by both the viral pol gene and the upstream gag gene. These two genes lie in different translational reading frames, with the 3' end of gag overlapping the 5' end of pol by 205 or 241 nucleotides. Thus, production of the gag-pol fusion protein would require either messenger RNA processing or translational frameshifting. The latter mechanism has been shown in the synthesis of the gag-pol proteins of two other retroviruses, Rous sarcoma virus (RSV) and mouse mammary tumour virus (MMTV). Here we report that translation of HIV-1 RNA synthesized in vitro by SP6 RNA polymerase yields significant amounts of a gag-pol fusion protein, indicating that efficient ribosomal frameshifting also occurs within the HIV-1 gag-pol overlap region. Site-directed mutagenesis and amino-acid sequencing localized the site of frameshifting to a UUA leucine codon near the 5' end of the overlap.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is estimated that a mature HIV-1 virion contains about 120 copies of IN protein8,9.”
From Structure and function of retroviral integrase (2022) · cites this paper as [8]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7035 · Cited by 6,324
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Nucleotide sequence of rous sarcoma virus
Schwartz, D. E., Tizard, R., & Gilbert, W. (1983) · Cell · doi:10.1016/0092-8674(83)90071-5 · Cited by 875
Genome organization and transactivation of the human immunodeficiency virus type 2
Guyader, M., Emerman, M., Sonigo, P., Clavel, F., Montagnier, L., & Alizon, M. (1987) · Nature · doi:10.1038/326662a0 · Cited by 848
Zoller, M. J., & Smith, M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.20.6487 · Cited by 745
Nucleotide Sequence and Expression of an AIDS-Associated Retrovirus (ARV-2)
Sanchez-Pescador, R., Power, M. D., Barr, P. J., Steimer, K. S., Stempien, M. M., Brown-Shimer, S. L., Gee, W. W., Renard, A., Randolph, A., Levy, J. A., et al. (1985) · Science · doi:10.1126/science.2578227 · Cited by 719
Self-citationNucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus
Muesing, M. A., Smith, D. H., Cabradilla, C. D., Benton, C. V., Lasky, L. A., & Capon, D. J. (1985) · Nature · doi:10.1038/313450a0 · Cited by 682
Uhlén, M., Guss, B., Nilsson, B., Gatenbeck, S., Philipson, L., & Lindberg, M. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43463-6 · Cited by 566
Cited by
Items 401–500 of 955
Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules
Janson, C. G., & During, M. J. (2006) · Springer eBooks · doi:10.1007/0-387-32956-0 · Cited by 41
Immunological characterization of the gag gene products of bovine immunodeficiency virus
Battles, J. K., Hu, M., Rasmussen, L. A., Tobin, G. J., & Gonda, M. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.6868-6877.1992 · Cited by 41
Palde, P. B., Ofori, L. O., Gareiss, P. C., Lerea, J., & Miller, B. L. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100231t · Cited by 34
Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder
Grice, S. F. J. L. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_434 · Cited by 47
Charbonneau, J., Gendron, K., Ferbeyre, G., & Brakier‐Gingras, L. (2012) · RNA · doi:10.1261/rna.030346.111 · Cited by 36
Regulators of Viral Frameshifting: More Than RNA Influences Translation Events
Penn, W. D., Harrington, H. R., Schlebach, J. P., & Mukhopadhyay, S. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-012120-101548 · Cited by 36
Léger, M., Sidani, S., & Brakier‐Gingras, L. (2004) · RNA · doi:10.1261/rna.7670704 · Cited by 40
Gowda, S. D., Stein, B. S., Steimer, K. S., & Engleman, E. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1451-1454.1989 · Cited by 37
Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active
Kotler, M., Arad, G., & Hughes, S. H. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6781-6783.1992 · Cited by 34
Viral gene products and replication of the human immunodeficiency type 1 virus
Morrow, C. D., Park, J., & Wakefield, J. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.5.c1135 · Cited by 49
Navia, M. A., & McKeever, B. M. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17829.x · Cited by 34
Human Immunodeficiency Virus Type 1 Nucleocapsid p1 Confers ESCRT Pathway Dependence
Popova, E., Popov, S., & Göttlinger, H. G. (2010) · Journal of Virology · doi:10.1128/jvi.00035-10 · Cited by 35
Thinking Outside the Frame: Impacting Genomes Capacity by Programmed Ribosomal Frameshifting
Riegger, R. J., & Caliskan, N. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.842261 · Cited by 36
Multimodal Functionalities of HIV-1 Integrase
Engelman, A., & Kvaratskhelia, M. (2022) · Viruses · doi:10.3390/v14050926 · Cited by 41
Design of a trans protease lentiviral packaging system that produces high titer virus
Westerman, K. A., Ao, Z., Cohen, É. A., & Leboulch, P. (2007) · Retrovirology · doi:10.1186/1742-4690-4-96 · Cited by 33
[32] Functional significance of myristoyl moiety in N-myristoyl proteins
Knoll, L. J., Johnson, D. R., Bryant, M. L., & Gordon, J. I. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)50088-x · Cited by 33
RNA pseudoknots downstream of the frameshift sites of retroviruses
Le, S., Shapiro, B. A., Chen, J.-H., Nussinov, R., & Maizel, J. V. (1991) · Genetic Analysis Biomolecular Engineering · doi:10.1016/1050-3862(91)90013-h · Cited by 33
Fontenot, G. K., Johnston, K. H., Cohen, J., Gallaher, W. R., Robinson, J. E., & Luftig, R. B. (1992) · Virology · doi:10.1016/0042-6822(92)91186-x · Cited by 35
Qiang, Y., Ottmann, M., Péchoux, C., Grice, S. F. J. L., & Darlix, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7676-7680.1998 · Cited by 36
HIV-1 Capsid Core: A Bullet to the Heart of the Target Cell
Toccafondi, E., Lener, D., & Negroni, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.652486 · Cited by 33
Novel viral translation strategies
Au, H. H. T., & Jan, E. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1246 · Cited by 41
A novel HIV vaccine targeting the protease cleavage sites
Li, H., Omange, R. W., Plummer, F. A., & Luo, M. (2017) · AIDS Research and Therapy · doi:10.1186/s12981-017-0174-7 · Cited by 32
Girnary, R., King, L. M., Robinson, L. H., Elston, R., & Brierley, I. (2006) · Journal of General Virology · doi:10.1099/vir.0.82064-0 · Cited by 32
Schröder, H. C., Bégin, M. E., Klöcking, R., Matthes, E., SARMA, A. S., Gašić, M. J., & Müller, W. E. G. (1991) · Virus Research · doi:10.1016/0168-1702(91)90034-s · Cited by 32
Peng, C., CHANG, N. T., & Chang, T. W. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2751-2756.1991 · Cited by 35
Human Immunodeficiency Virus Structure: Implications for Antiviral Design
Arnold, E., & Arnold, G. F. (1991) · Advances in virus research · doi:10.1016/s0065-3527(08)60792-7 · Cited by 36
Cryo-EM structure of the HIV-1 Pol polyprotein provides insights into virion maturation
Harrison, J. J. E. K., Passos, D. O., Bruhn, J. F., Bauman, J. D., Tuberty, L., DeStefano, J. J., Ruiz, F. X., Lyumkis, D., & Arnold, E. (2022) · Science Advances · doi:10.1126/sciadv.abn9874 · Cited by 31
The development of single molecule force spectroscopy: from polymer biophysics to molecular machines
Bustamante, C., & Yan, S. (2022) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583522000087 · Cited by 40
High-throughput interrogation of programmed ribosomal frameshifting in human cells
Mikl, M., Pilpel, Y., & Segal, E. (2020) · Nature Communications · doi:10.1038/s41467-020-16961-8 · Cited by 36
Hanners, N. W., Mar, K. B., Boys, I. N., Eitson, J. L., Cruz-Rivera, P. C. D. L., Richardson, R. B., Fan, W., Wight‐Carter, M., & Schoggins, J. W. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111266118 · Cited by 32
Bao, C., Zhu, M., Nykonchuk, I., Wakabayashi, H., Mathews, D. H., & Ermolenko, D. N. (2022) · Nature Communications · doi:10.1038/s41467-022-28600-5 · Cited by 40
Targeting RNAs with Tobramycin Analogues
Liang, F., Wang, S., Nakatani, T., & Wong, C. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460558 · Cited by 37
Development of peptide inhibitors of HIV transmission
Shi, S., Nguyen, P. K., Cabral, H., Diez-Barroso, R., Derry, P. J., Kanahara, S. M., & Kumar, V. (2016) · Bioactive Materials · doi:10.1016/j.bioactmat.2016.09.004 · Cited by 33
Upstream stimulators for recoding
Larsen, B., Brady, K., Atkins, J. F., Peden, J. F., Matsufuji, S., Matsufuji, T., Maldonado, R., Wills, N. M., Gesteland, R. F., & Fayet, O. (1995) · Biochemistry and Cell Biology · doi:10.1139/o95-121 · Cited by 35
Falk, H., Mador, N., Udi, R., Panet, A., & Honigman, A. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6273-6277.1993 · Cited by 31
Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV
Himmel, D. M., & Arnold, E. (2020) · Pharmaceuticals · doi:10.3390/ph13060122 · Cited by 30
Predicting ribosomal frameshifting efficiency
Cao, S., & Chen, S. (2008) · Physical Biology · doi:10.1088/1478-3975/5/1/016002 · Cited by 30
Conformational dynamics of the frameshift stimulatory structure in HIV-1
Ritchie, D. B., Cappellano, T. R., Tittle, C., Rezajooei, N., Rouleau, L., Sikkema, W. K. A., & Woodside, M. T. (2017) · RNA · doi:10.1261/rna.061655.117 · Cited by 30
Wang, C.-T., Chou, Y.-C., & Chiang, C.-C. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3418-3422.2000 · Cited by 30
Overton, H. A., McMillan, D. J., Gridley, S. J., Brenner, J., Redshaw, S. D., & MILLS, J. S. (1990) · Virology · doi:10.1016/0042-6822(90)90326-m · Cited by 30
Co, E., Koelsch, G., Lin, Y., Ido, E., Hartsuck, J. A., & Tang, J. (1994) · Biochemistry · doi:10.1021/bi00171a027 · Cited by 30
Chiu, H.-C., Yao, S.-Y., & Wang, C.-T. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3221-3231.2002 · Cited by 34
pCal, a highly unusual Ty1/copia retrotransposon from the pathogenic yeast Candida albicans
Matthews, G., Goodwin, T. J., Butler, M. I., Berryman, T. A., & Poulter, R. T. M. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.22.7118-7128.1997 · Cited by 33
The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation
Murphy, R. E., & Saad, J. S. (2020) · Viruses · doi:10.3390/v12050548 · Cited by 30
“GagPol, which contains the elements of Gag as well as the viral enzymes protease (PR), reverse transcriptase (RT) and integrase (IN), is produced and incorporated at lower levels relative to Gag (~5%) due to an infrequent ribosomal frameshift event [8,9].”
BackgroundProtein transduction by pseudotyped lentivirus-like nanoparticles
Aoki, T., Miyauchi, K., Urano, E., Ichikawa, R., & Komano, J. A. (2011) · Gene Therapy · doi:10.1038/gt.2011.38 · Cited by 31
Malbec, M., Sourisseau, M., Guivel‐Benhassine, F., Porrot, F., Blanchet, F. P., Schwartz, O., & Casartelli, N. (2013) · Retrovirology · doi:10.1186/1742-4690-10-80 · Cited by 36
HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors
Spearman, P. W. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150902102143 · Cited by 37
Beißinger, M., Paulus, C., Bayer, P., Wolf, H. J., ROSCH, P. J., & Wagner, R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0383k.x · Cited by 29
HIV-1 Replication and Potential Targets for Intervention
Stevenson, M., Bukrinsky, M., & Haggerty, S. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.107 · Cited by 29
Wu, X., Liu, H., Xiao, H., Conway, J. A., & Kappes, J. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3378-3384.1996 · Cited by 29
Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition
Connolly, K. J., & Sm, H. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.3.509 · Cited by 29
HIV-1 translation and its regulation by cellular factors PKR and PACT
Burugu, S., Daher, A., MEURS, E. F., & Gatignol, A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.014 · Cited by 38
Huang, S., Wang, S., Lin, Y.-T., Yen, C., Lee, C.-H., Wong, W. W., Tsai, H., Yang, C., Hu, B.-S., Lin, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114441 · Cited by 31
Huang, X., Yang, Y., Wang, G., Cheng, Q., & Du, Z. (2014) · RNA · doi:10.1261/rna.042457.113 · Cited by 30
Männik, A., Rünkorg, K., Jaanson, N., Ustav, M., & Ustav, E. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5835-5845.2002 · Cited by 28
HIV‐1 Protease inhibitors: Their development, mechanism of action and clinical potential
Pillay, D., Bryant, M. L., Getman, D. P., & Richman, D. D. (1995) · Reviews in Medical Virology · doi:10.1002/rmv.1980050104 · Cited by 31
Bures, M. G., Hutchins, C. W., MAUS, M. L., Kohlbrenner, W. E., KADAM, S. K., & Erickson, J. W. (1990) · Tetrahedron Computer Methodology · doi:10.1016/0898-5529(90)90166-6 · Cited by 28
Veres, G., Escaich, S., Baker, J., Barske, C., Kalfoglou, C., Ilves, H., Kaneshima, H., & Böhnlein, E. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8792-8800.1996 · Cited by 28
Sk, M. F., Jonniya, N. A., & Kar, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1794965 · Cited by 27
Targeting Ribosomal Frameshifting as an Antiviral Strategy: From HIV-1 to SARS-CoV-2
Anokhina, V. S., & Miller, B. L. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00316 · Cited by 29
Paulus, C., Ludwig, C., & Wagner, R. (2004) · Virology · doi:10.1016/j.virol.2004.09.013 · Cited by 27
Megede, J. Z., Otten, G. R., Doe, B., Liu, H., Leung, L., Ulmer, J. B., Donnelly, J., & Barnett, S. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6197-6207.2003 · Cited by 29
Sandmeyer, S. B., & Menees, T. M. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80145-7_9 · Cited by 30
Translation controls the expression level of a chimaeric reporter gene
Hensgens, L. A. M., Fornerod, M. W. J., Rueb, S., Winkler, A. A., van der Veen, S., & Schilperoort, R. A. (1992) · Plant Molecular Biology · doi:10.1007/bf00027163 · Cited by 27
Liao, W.-H., & Wang, C.-T. (2004) · Virology · doi:10.1016/j.virol.2004.08.010 · Cited by 30
In vitro inhibition of HIV‐1 proteinase by cerulenin
Moelling, K., Schulze, T., Knoop, M.-T., Kay, J., Jupp, R. A., Nicolaou, G., & Pearl, L. H. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80595-a · Cited by 27
Vernon, S. K., Murthy, S., Wilhelm, J., Chanda, P. K., Kalyan, N. K., Lee, S.-G., & Hung, P. P. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-6-1243 · Cited by 28
Identification of a Minimal HIV-1 Gag Domain Sufficient for Self-Association
Zábranský, A., Hunter, E., & Sakalian, M. (2002) · Virology · doi:10.1006/viro.2001.1315 · Cited by 28
Halsey, R. J., Tanzer, F. L., Meyers, A. E., Pillay, S., Lynch, A. G., Shephard, E., Williamson, A., & Rybicki, E. P. (2008) · Virus Research · doi:10.1016/j.virusres.2008.01.012 · Cited by 30
The Cys-His motif of Ty3 NC can be contributed by Gag3 or Gag3-Pol3 polyproteins
Orlinsky, K. J., & Sandmeyer, S. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4152-4166.1994 · Cited by 26
Ro, Y. T., Scheffter, S. M., & Patterson, J. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.8983-8990.1997 · Cited by 26
Lee, Y. M., Tian, C., & Yu, X. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9061-9068.1998 · Cited by 26
Hill, M. K., Hooker, C. W., Harrich, D., Crowe, S. M., & Mak, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6835-6840.2001 · Cited by 27
Polycistronic Animal Virus mRNAs
Samuel, C. E. (1989) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60697-2 · Cited by 27
Bathurst, I., Chester, N., Gibson, H. L., Dennis, A., Steimer, K. S., & Barr, P. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.7.3176-3179.1989 · Cited by 28
Self-citationLuban, J., Lee, C., & Goff, S. P. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3630-3634.1993 · Cited by 30
Asbach, B., Kliche, A., Köstler, J., Perdiguero, B., Estéban, M., Jacobs, B. L., Montefiori, D. C., LaBranche, C. C., Yates, N. L., Tomaras, G. D., et al. (2016) · Journal of Virology · doi:10.1128/jvi.03135-15 · Cited by 29
Arora, J., McLaren, P. J., Chaturvedi, N., Carrington, M. N., Fellay, J., & Lenz, T. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812548116 · Cited by 25
First isolation of an Entomobirnavirus from free-living insects
Marklewitz, M., Gloza‐Rausch, F., Kurth, A. A., Kümmerer, B. M., Drosten, C., & Junglen, S. (2012) · Journal of General Virology · doi:10.1099/vir.0.045435-0 · Cited by 25
Yang, O. O., Daar, E. S., Ng, H. L., Shih, R., & Jamieson, B. D. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0183 · Cited by 25
Almog, N., Roller, R. J., Arad, G., Passi-Even, L., Wainberg, M. A., & Kotler, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7228-7232.1996 · Cited by 25
Kang, H. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00004-9 · Cited by 25
Discontinuous Triplet Decoding with or without Re-Pairing by Peptidyl tRNA
Atkins, J. F., & Gesteland, R. F. (2014) · ASM Press eBooks · doi:10.1128/9781555818333.ch23 · Cited by 25
Saitoh, A., Iwasaki, H., Nakata, A., Adachi, A., & Shinagawa, H. (1990) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1990.tb03168.x · Cited by 25
Rehfeld, F., Eitson, J. L., Ohlson, M. B., Chang, T.-C., Schoggins, J. W., & Mendell, J. T. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112076 · Cited by 29
Structural Properties of HIV Integrase·Lens Epithelium-derived Growth Factor Oligomers
Gupta, K., Diamond, T., Hwang, Y., Bushman, F., & Van Duyne, G. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114413 · Cited by 24
Chou, M.-Y., & Chang, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1107 · Cited by 24
Aupeix-Scheidler, K. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.2.438 · Cited by 24
Mechanisms of mRNA frame maintenance and its subversion during translation of the genetic code
Dunkle, J. A., & Dunham, C. M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.02.007 · Cited by 27
Wills, N. M., & Atkins, J. F. (2006) · RNA · doi:10.1261/rna.84406 · Cited by 24
Obstacles to successful antiretroviral treatment of HIV-1 infection: problems & perspectives.
Potter, S. J., Chew, C. B., Steain, M. C., Dwyer, D. E., & Saksena, N. K. (2004) · PubMed · Cited by 30
Incorporation of tRNA into normal and mutant HIV-1
Kleiman, L., Caudry, S. D., Boulerice, F., Wainberg, M. A., & Parniak, M. A. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91559-u · Cited by 32
Hayakawa, T., Misumi, Y., Kobayashi, M., Yamamoto, Y., & Fujisawa, Y. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17001.x · Cited by 26
Recognition of out‐of‐frame major histocompatibility complex class I‐restricted epitopes in vivo
Elliott, T. J., Bodmer, H. C., & Townsend, A. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260532 · Cited by 25
Influence of the Small Leader Exons 2 and 3 on Human Immunodeficiency Virus Type 1 Gene Expression
Krummheuer, J., Lenz, C., Kammler, S., Scheid, A., & Schaal, H. (2001) · Virology · doi:10.1006/viro.2001.0974 · Cited by 29
Expression and Processing of Proteins Encoded by the Saccharomyces Retrotransposon Ty5
Irwin, P. A., & Voytas, D. F. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1790-1797.2001 · Cited by 24
Interactions between HIV-1 protease, silver nanoparticles, and specific peptides
Tsai, C.-H., Whiteley, C. G., & Lee, D. (2019) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2019.07.019 · Cited by 23
Tinoco, I., Kim, H., & Yan, S. (2013) · Biopolymers · doi:10.1002/bip.22293 · Cited by 27
Regulation of KiSS1 gene expression
Li, D., Yu, W., & Liu, M. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.025 · Cited by 24
De Novo variants in EEF2 cause a neurodevelopmental disorder with benign external hydrocephalus
Sá, M. J. N., Olson, A. N., Yoon, G., Nimmo, G. A. M., Gomez, C. M., Willemsen, M. A. A. P., Millan, F., Schneider, A., Pfundt, R., de Brouwer, A. P. M., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa270 · Cited by 22
Metadata
- Authors
- Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., & Varmus, H. E.
- Affiliations
- University of California, San Francisco (US)
- University of California, Davis (US)
- Venue
- Nature
- Published
- 1988-01
- Volume
- 331
- Issue
- 6153
- Pages
- 280-283
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2089471930
- Cited by
- 966
- References
- 24
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 21 · 2023: 10 · 2022: 27 · 2021: 25 · 2020: 25 · 2019: 15 · 2018: 14 · 2017: 22 · 2016: 21 · 2015: 29 · 2014: 36 · 2013: 20 · 2012: 28
- FWCI
- 22.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- ribosomal frameshifting, HIV-1, Gag-Pol polyprotein, translational frameshifting, site-directed mutagenesis, in vitro transcription, retroviral gene expression
- MeSH terms
- Amino Acid Sequence, Base Sequence, HIV, Molecular Sequence Data, Nucleic Acid Conformation, Retroviridae Proteins, RNA-Directed DNA Polymerase, Ribosomes, Protein Biosynthesis, Viral Fusion Proteins, Gene Products, gag
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.